LIR Life Sciences Corp. (CNSX: SKNY)
Health Care · Pharmaceuticals · CA
CA$0.24
+77.78% today · -80.3% 1Y
LIR Life Sciences Corp. (CNSX: SKNY) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $4.85M.
Over the last twelve months the share price has lost 80.3%, trading between 0.10 and 2.41.
Tweenvest scores LIR Life Sciences Corp. across four factors: quality 42/100, value 66/100. Its strongest factor is value.
SKNY price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $4.85M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.18
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- CA$2.41
- 52-week low
- CA$0.10
- Avg volume (3M)
- —
- Shares outstanding
- 28.67M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Biofil Chemicals and Pharmaceuticals LimitedBSE: 524396 | $5.01M | Rs29.64 | -9.50% |
| Enorama Pharma AB (publ)OM: ERMA | $4.97M | Skr0.61 | -8.96% |
| Vivimed Labs LimitedNSEI: VIVIMEDLAB | $4.92M | Rs5.71 | +2.88% |
| 60 Degrees Pharmaceuticals, Inc.NasdaqCM: SXTP | $4.89M | $0.97 | -30.04% |
| Sweet Earth Holdings CorporationCNSX: SE | $4.79M | CA$— | — |
| Mangalam Drugs & Organics LimitedBSE: 532637 | $4.77M | Rs29.00 | -9.09% |
| Vasundhara Rasayans LimitedBSE: 538634 | $4.77M | Rs144.40 | -9.15% |
| Lexaria Bioscience Corp.NasdaqCM: LEXX | $4.76M | $3.20 | +11.11% |
Figures last refreshed Oct 4, 2026.